Evidence map›Paper›PMID 31070821›Full record

ArticleMolecular microbiology2019

The Campylobacter jejuni helical to coccoid transition involves changes to peptidoglycan and the ability to elicit an immune response.

Emilisa Frirdich, Jacob Biboy, Mark Pryjma, Jooeun Lee, Steven Huynh, Craig T Parker, Stephen E Girardin, Waldemar Vollmer, Erin C Gaynor

Open access · hybridAbstract read
In one paragraph

Article in Molecular microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Cas9 modulatesMicrobiology (Reading, England) · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2023
    Review
  8. MultipleFrontiers in microbiology · 2023
    Article
  9. Survival ofMicroorganisms · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Seasonal Prevalence and Molecular Identification of ThermophilicInternational journal of microbiology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Regulation of peptidoglycan synthesis and remodelling.Nature reviews. Microbiology · 2020
    Review
  18. Review
  19. Review on Stress Tolerance inFrontiers in cellular and infection microbiology · 2020
    Review
  20. Comparative Analysis of Peptidoglycans FromFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Emilisa FrirdichDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-9710-9410
Jacob BiboyThe Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Mark PryjmaDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.
Jooeun LeeDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Steven HuynhProduce Safety and Microbiology Unit, Western Region Research Center, USDA, Agricultural Research Service, Albany, CA, USA.
Craig T ParkerProduce Safety and Microbiology Unit, Western Region Research Center, USDA, Agricultural Research Service, Albany, CA, USA.ORCID 0000-0002-7719-8882
Stephen E GirardinDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Waldemar VollmerThe Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Erin C GaynorDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.
University of British Columbia · CAAgricultural Research Service · USNewcastle University · GBUniversity of Toronto · CA

Funding

CIHR MOP-68981Wellcome TrustWellcome Trust 101824/Z/13/Z
6 · The paper itself

Abstract

Campylobacter jejuni is a prevalent enteric pathogen that changes morphology from helical to coccoid under unfavorable conditions. Bacterial peptidoglycan maintains cell shape. As C. jejuni transformed from helical to coccoid, peptidoglycan dipeptides increased and tri- and tetrapeptides decreased. The DL-carboxypeptidase Pgp1 important for C. jejuni helical morphology and putative N-acetylmuramoyl-L-alanyl amidase AmiA were both involved in the coccoid transition. Mutants in pgp1 and amiA showed reduced coccoid formation, with ∆pgp1∆amiA producing minimal coccoids. Both ∆amiA and ∆amiA∆pgp1 lacked flagella and formed unseparated chains of cells consistent with a role for AmiA in cell separation. All strains accumulated peptidoglycan dipeptides over time, but only strains capable of becoming coccoid displayed tripeptide changes. C. jejuni helical shape and corresponding peptidoglycan structure are important for pathogenesis-related attributes. Concomitantly, changing to a coccoid morphology resulted in differences in pathogenic properties; coccoid C. jejuni were non-motile and non-infectious, with minimal adherence and invasion of epithelial cells and an inability to stimulate IL-8. Coccoid peptidoglycan exhibited reduced activation of innate immune receptors Nod1 and Nod2 versus helical peptidoglycan. C. jejuni also transitioned to coccoid within epithelial cells, so the inability of the immune system to detect coccoid C. jejuni may be significant in its pathogenesis.

Indexed as

Bacterial ProteinsCampylobacter InfectionsCampylobacter jejuniCarboxypeptidasesCell ShapeCell WallPeptidoglycanBacterial ProteinsCarboxypeptidasesPeptidoglycan

Identifiers

PMID31070821
PMCPMC6767375
OpenAlexW2944745053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.